Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX.

Autor: So Heun Lee1, Dae Wook Hwang2, Changhoon Yoo1 yooc@amc.seoul.kr, Kyu-pyo Kim1 drksc@amc.seoul.kr, Sora Kang3, Jae Ho Jeong1, Dongwook Oh4, Tae Jun Song4, Sang Soo Lee4, Do Hyun Park4, Dong Wan Seo4, Jin-hong Park5, Ki Byung Song2, Jae Hoon Lee2, Woohyung Lee2, Yejong Park2, Bong Jun Kwak2, Heung-Moon Chang1, Baek-Yeol Ryoo1, Song Cheol Kim2
Zdroj: Cancer Research & Treatment. Jul2023, Vol. 55 Issue 3, p956-966. 13p.
Databáze: Academic Search Ultimate